NICHOL GEOFFREY 4
4 · Tempest Therapeutics, Inc. · Filed Jun 20, 2023
Insider Transaction Report
Form 4
NICHOL GEOFFREY
Director
Transactions
- Award
Stock Option (right to buy)
2023-06-15+8,200→ 8,200 totalExercise: $1.42Exp: 2033-06-14→ Common Stock (8,200 underlying)
Footnotes (1)
- [F1]The shares underlying the option will vest in full on the earlier of (i) June 15, 2024, or (ii) the day of the Issuer's 2024 annual stockholder meeting, subject to the Reporting Person's continuous service through such vesting date.